BC Partners is nearing a deal to sell Dutch generic drugmaker Synthon International Holding BV to Goldman Sachs Asset ...

Goldman Sachs Group Inc.’s alternative investment arm has agreed to buy a majority stake in Dutch generic drugmaker Synthon ...

Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to people familiar with the matter, as it hopes to capitalise on demand for off ...

BC Partners has agreed to sell its majority stake in Synthon to Goldman Sachs Alternatives. Synthon is an international pharmaceutical company, with a platform specialized in developing, manufacturing ...

Goldman Sachs Asset Management (GS) is nearing a more than EUR 2B deal to buy drugmaker Synthon from BC Partners, people familiar tell the ...

Goldman Sachs’ asset arm is in the process of acquiring the Dutch pharmaceutical company Synthon International for 2 billion ...

Bankers and direct lenders are going head-to-head to provide as much as €1 billion ($1.05 billion) of debt financing to help fund a potential sale of pharmaceutical firm Synthon, according to people ...

Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "Companion Diagnostic Collaboration and Licensing Deals 2010-2024" report has been added to ResearchAndMarkets.com's offering. Companion Diagnostic ...

Satellite images reveal Russian military equipment being prepared for loading, a possible prelude to its withdrawal from Syria. Travis Timmerman, an American who was found earlier this week, was ...

Months Before C.E.O.’s Killing, the Suspect Went Silent. Where Was He? New details are emerging about Luigi Mangione’s growing impatience with “a capitalist society” and his search for ...

South Africa sweep Sri Lanka 2-0 to lead World Test Championship table Maharaj’s five-for helps South Africa beat Sri Lanka by 109 runs and leap ahead of Australia and India on the WTC table ...